TABLE 1.
Clinical data
Cohort | n | Age (years) | Age | Sex (women/men) | T1D+CD | Early onset T1D | Long-lasting T1D |
---|---|---|---|---|---|---|---|
T1D | 10 | 3–58 | 29 ± 5.2 | 7/3 | 5 of 10 | 3 of 10 | 7 of 10 |
Healthy | 16 | 2–68 | 11.6 ± 4 | 10/6 | NA | NA | NA |
CD | 20 | 2–19 | 7.9 ± 1.2 | 15/5 | NA | NA | NA |
Data are means ± SD unless otherwise indicated. All patients (N = 46) underwent esophago-gastro-duodenal endoscopy for a clinical suspect of CD. The diagnosis of CD was made out of the histological examination of the intestinal mucosa and of the presence of antitissue transglutaminase antibodies (>95% of celiac individuals were tissue transglutaminase IgG and IgA positive). Hence, all the patients with CD were on a normal (not gluten-free) diet at the time of biopsy collection. HC subjects and patients affected only by T1D were all tissue transglutaminase IgG/IgA negative (100%). The mean age in the T1D group was higher than that of control individuals (healthy individuals and subjects with CD); however, we found no statistical correlation between age and the percentage of CD4+CD25+FoxP3+CD127− Treg cells in the gut mucosa (r2 = 0.05). Early onset T1D, <6 months from diagnosis; long-lasting T1D, ≥6 months from diagnosis. All samples analyzed were donated for research purposes and each individual signed an informed consent.